Exosome Scalp Microneedling

Exosome scalp microneedling is being investigated primarily for hair loss conditions, specifically androgenetic alopecia (male and female pattern baldness) and self-perceived hair thinning. The treatment combines topical application of exosomes with microneedling to potentially enhance penetration and efficacy.

Conditions and Treatment Goals

Based on available clinical evidence, this therapy is being studied for:

• Androgenetic alopecia (male and female pattern hair loss)
• Self-perceived hair thinning in both men and women
• Non-scarring alopecia conditions

The primary treatment goals include promoting hair regrowth, increasing hair density, and improving overall scalp health in patients experiencing hair loss.

Clinical Evidence

Current evidence for exosome scalp microneedling remains limited but emerging. Several clinical trials are underway or recently completed:

• NCT06571799: A completed study evaluated the BENEV Exosome Regenerative Complex for self-perceived thinning hair, though results are not yet published
• NCT06999408: An active trial combining TargetCool technology with BENEV exosomes for hair thinning
• NCT07373054: An ongoing study specifically examining umbilical cord mesenchymal stem cell-derived exosomes for androgenic alopecia

Research Findings

One published study (PMID: 41037530) investigated "An Exosome Regenerative Complex Plus Microneedling" and reported promotion of hair growth in subjects with self-perceived thinning hair. However, detailed efficacy data and patient outcomes from these studies are not available in the provided evidence.

Additional research has explored biomarkers for treatment response, with one study (PMID: 42073416) examining how baseline neutrophil-to-lymphocyte ratios might predict early response to platelet-rich plasma treatments in non-scarring alopecia, though this focused on PRP rather than exosomes specifically.

Current Status

The clinical application of exosome scalp microneedling for hair loss is still investigational. While multiple trials are in progress, published peer-reviewed data demonstrating clear efficacy and safety profiles remain sparse. Most evidence comes from ongoing or recently completed clinical trials rather than established clinical practice.

This information is for educational purposes only and should not replace consultation with a qualified healthcare provider for personalized medical advice regarding hair loss treatment options.